Each trading day, our technical scanner evaluates hundreds of S&P 500 and Nasdaq 100 constituents across a broad range of indicators — moving averages, momentum oscillators, volume patterns and more — to surface stocks where bearish signals are accumulating. The five names below registered the highest number of technical sell signals on 23 July 2026, making them potential short candidates worthy of closer scrutiny. A short candidate is simply a stock where technical evidence suggests weakening price momentum or deteriorating trend structure.
Important risk warning: Short selling carries substantially greater risk than holding a long position. Losses on a short trade are theoretically unlimited, margin requirements add complexity, and stocks can be subject to short squeezes that move prices sharply against the position. The analysis below is purely technical in nature and should not be treated as a recommendation to sell or short any security. Always conduct your own due diligence and consider your personal risk tolerance before acting.
1. Principal Financial Group (PFG) – 15 technical sell signals
Price: $108.25 | Daily change: -1.2%
View the full technical analysis of Principal Financial Group
Principal Financial Group leads today’s scan with 15 bearish technical signals against just 2 bullish ones — the widest imbalance in our top five. The stock has been a notable outperformer over the past year, having gained more than 36% while its broader industry managed only a modest advance. That kind of extended run can itself become a technical headwind: when a stock trades in the vicinity of multi-year highs, momentum indicators frequently begin to roll over even before price does, and that appears to be what the scanner is detecting here.
Analysts have recently weighed in with mixed tones. While some commentators cited the stock’s proximity to its 52-week high as a potential exit signal for investors who have already captured a substantial gain, others continue to highlight PFG’s longer-term business positioning, including a recently announced expansion into the dental benefits space through the proposed acquisition of Alabama-based DentaNet. Strategically, that deal could broaden the company’s insurance platform, but near-term integration costs and execution risk are factors worth weighing.
From a purely technical standpoint, the combination of a stock trading near resistance after a prolonged rally, alongside a heavy preponderance of sell signals, warrants attention. The two bull signals in the reading offer a modest counterpoint, suggesting the bearish case is not entirely uncontested, and prospective short sellers should remain alert to the possibility of renewed buying interest near current levels.
2. Align Technology (ALGN) – 14 technical sell signals
Price: $172.46 | Daily change: -2.84%
View the full technical analysis of Align Technology
Align Technology sits in joint second place with 14 technical sell signals, and today’s session decline of nearly 3% adds a degree of urgency to the picture. The maker of Invisalign clear aligners is approaching a significant catalyst: the company is scheduled to report second-quarter earnings on 29 July, with investors focused particularly on volume trends in the Clear Aligner segment and the uptake of newer digital product offerings. Pre-earnings periods can amplify both bearish and bullish technical patterns, so the timing here is meaningful.
Analyst opinion on ALGN has been characterised as mixed in recent coverage, with at least one prominent healthcare analyst maintaining a constructive long-term view while others have flagged uncertainty around consumer demand for elective dental procedures in the current economic environment. The stock has also attracted attention from value-oriented commentators, which may indicate that some investors see the recent weakness as an opportunity — a factor that could create a cushion against a deeper near-term decline.
For technically-minded investors, the key question is whether the cluster of sell signals reflects genuine distribution ahead of earnings or simply pre-announcement nervousness. Either way, the asymmetric risk profile of shorting into an imminent earnings release — where a positive surprise could trigger a sharp reversal — makes this a particularly high-risk short candidate compared with others on this list.
3. Palantir Technologies (PLTR) – 14 technical sell signals
Price: $124.57 | Daily change: -6.1%
View the full technical analysis of Palantir Technologies
Palantir Technologies is the most dramatic mover in today’s list, falling more than 6% in a single session and matching Align Technology on 14 technical sell signals. Recent news flow sheds light on the selling pressure: reports indicate that a company director offloaded more than $2 million worth of shares in mid-July, and targeted regulatory concerns around its AI-related business activities appear to have weighed on sentiment on Wednesday. Insider selling at these levels, regardless of the stated rationale, is a factor that technical traders often treat as a bearish signal in its own right.
The stock’s 2026 trajectory has been turbulent. Despite strong underlying revenue growth, PLTR has shed more than 24% year-to-date, reflecting the market’s ongoing debate about whether its valuation — which remains elevated by most conventional measures — can be sustained. Commentators have noted that the stock sits at the more expensive end of the AI-sector valuation spectrum, and with Wall Street deeply divided on its merits, price volatility is likely to remain a defining feature.
The three bull signals in today’s reading are a reminder that not every technical indicator has turned negative, and the stock’s established AI growth narrative retains genuine appeal for many long-term investors. Prospective short sellers should be mindful that any positive development in its government or commercial contract pipeline could trigger a swift and sizeable rebound.
4. Roper Technologies (ROP) – 14 technical sell signals
Price: $336.71 | Daily change: -3.99%
View the full technical analysis of Roper Technologies
Roper Technologies rounds out the trio of stocks sharing 14 sell signals, and it stands out for carrying only a single bull signal — the lowest bull reading in today’s entire top five. The industrial technology and software conglomerate fell close to 4% in today’s session, a notable decline for a stock in a sector that tends to exhibit relatively steady price behaviour. With just one indicator pointing in a constructive direction, the technical picture here is arguably the most one-sided of the group.
The fundamental backdrop presents an interesting contrast. Sell-side analysts have been broadly constructive on Roper’s software momentum and acquisition strategy, with some pointing to potential upside of more than 25% from recent levels based on their fair value models. The stock has also made gains over the past several weeks before today’s pullback, suggesting that some profit-taking may be contributing to the current weakness. A recently declared dividend also reflects a degree of management confidence in the company’s cash generation.
Nevertheless, when technical deterioration is this pronounced — with 14 indicators flashing caution and only one offering support — it is worth taking the signal seriously, particularly in a broader market environment where risk appetite can shift quickly. Investors considering a short position should weigh the analyst community’s relatively positive fundamental stance, which represents a meaningful headwind to any bearish trade.
5. GE HealthCare (GEHC) – 13 technical sell signals
Price: $61.41 | Daily change: -1.02%
View the full technical analysis of GE HealthCare
GE HealthCare closes out our list with 13 technical sell signals, though it is worth noting that it also carries 7 bull signals — the highest bull reading of any stock in today’s top five. That more balanced reading suggests the technical picture is less decisively bearish than it is for some of the names above. Today’s session decline was relatively contained at just over 1%, and the stock’s recent news flow has been constructively focused on innovation and regulatory progress.
GEHC has been active on several fronts. The company received FDA clearance for an AI-powered radiation therapy planning tool, and separately announced a research collaboration with Mayo Clinic targeting personalised cancer treatment using theranostics — a growing field that combines diagnostic imaging with targeted therapy. These developments have attracted attention from healthcare-focused investors and hedge funds, and the stock has been cited among the holdings of several institutional portfolios with a healthcare growth mandate.
The disconnect between a relatively active positive news cycle and a meaningful cluster of technical sell signals is the core tension in the GEHC case. It may reflect broader sector rotation or profit-taking after a period of strong performance, rather than any fundamental deterioration. For that reason, this is perhaps the most contested short candidate on today’s list, and any position taken against it should be sized and managed accordingly.
Disclaimer: This blog post is produced for informational and educational purposes only and does not constitute investment advice or a solicitation to buy or sell any security. Technical analysis is one tool among many and does not guarantee future price performance. Short selling involves significant risk, including the potential for unlimited losses. Past performance is not indicative of future results. Members of the Wall Street Stock Investors Club should always conduct independent research and consult a qualified financial adviser before making any investment decision.